APA-viite

Atashrazm, F., & Dzamko, N. (2016). LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: Current perspectives. Clin Pharmacol.

Chicago-tyylinen lähdeviittaus

Atashrazm, Farzaneh, ja Nicolas Dzamko. "LRRK2 Inhibitors and Their Potential in the Treatment of Parkinson’s Disease: Current Perspectives." Clin Pharmacol 2016.

MLA-viite

Atashrazm, Farzaneh, ja Nicolas Dzamko. "LRRK2 Inhibitors and Their Potential in the Treatment of Parkinson’s Disease: Current Perspectives." Clin Pharmacol 2016.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.